Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Complement and the damaging effects of cardiopulmonary bypass
1983 Standout
Isolation and characterization
2006 Standout
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts
2006 StandoutNobel
Bacterial Biofilms in Nature and Disease
1987 Standout
Inclusion body myositis and myopathies
1995 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Complement and its role in innate and adaptive immune responses
2009 Standout
Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.
1991
Paroxysmal Nocturnal Hemoglobinuria
1992
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
2003 Standout
Inflammatory response to cardiopulmonary bypass
1993 Standout
Cytokine enhancement of complement‐dependent phagocytosis by macrophages: synergy of tumor necrosis factor‐α and granulocyte‐macrophage colony‐stimulating factor for phagocytosis of Cryptococcus neoformans
1992
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
1991 Standout
Protective effects of C5a blockade in sepsis
1999
Cleavage of the Third Component of Complement (C3) by Mannose-Binding Protein-Associated Serine Protease (MASP) with Subsequent Complement Activation
1995
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
CRYPTOCOCCAL INFECTION AND TH1-TH2 CYTOKINE BALANCE
2002
Chicken antibodies: a tool to avoid interference by complement activation in ELISA
1992 StandoutNobel
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
1994
The inflammatory response in myocardial infarction
2002 Standout
Anaphylatoxins and infectious and non-infectious inflammatory diseases
2001
Adenovirus-Mediated Blockade Of Tumor Necrosis Factor In Mice Protects Against Endotoxic Shock Yet Impairs Pulmonary Host Defense
1995 StandoutNobel
Spleen deposition ofCryptococcus neoformanscapsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1
2008 StandoutNobel
Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?
1996
The Pathophysiology and Treatment of Sepsis
2003 Standout
Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.
1989
Immunity to fungal infections
2011 Standout
Polymyositis and dermatomyositis
2003 Standout
Melioidosis: A Major Cause of Community-Acquired Septicemia in Northeastern Thailand
1989 Standout
Innate immunity: an overview
2003 StandoutNobel
Staphylococcus aureusInfections
1998 Standout
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
IL-12 and IFN- γ Are Required for Initiating the Protective Th1 Response to Pulmonary Cryptococcosis in Resistant C.B-17 Mice
1997 Standout
Role of Peptidoglycan from Staphylococcus aureus in Leukopenia, Thrombocytopenia, and Complement Activation Associated with Bacteremia
1982
Gram-Negative Rod Bacteremia: Microbiologic, Immunologic, and Therapeutic Considerations
1977
Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.
1977
Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3
1988
Role of Antibody and Complement in the Immune Clearance and Destruction of Erythrocytes I. IN VIVO EFFECTS OF IgG AND IgM COMPLEMENT-FIXING SITES
1972
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
1982 Standout
[13] Opsonins and dysopsonins: An overview
1986
The Spectrum of Vasculitis
1978 Standout
Immunochemistry of staphylococcal nuclease. II. Inhibition and binding studies with sequence fragments
1970 StandoutNobel
The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
1978
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Functional Specificity of Thymus-Dependent Lymphocytes
1977 StandoutScienceNobel
Genetic Aspects of the Complement System
1971
A galactoxylomannan antigen of Cryptococcus neoformans serotype A
1982
Activation of the complement system by pathogenic fungi
1996
The Fourth Component of Complement in the Cerebrospinal Fluid in Systemic Lupus Erythematosus
1973
Role of complement in in vitro and in vivo lung inflammatory reactions
1998
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography
1990
Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.
1994 StandoutNobel
Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP.
1975
Immunochemical characterization of murine H-2 controlled Ss (serum substance) protein through identification of its human homologue as the fourth component of complement.
1975
Gram-negative bacteremia
1980 Standout
Immunochemistry of staphylococcal nuclease. I. Physical, enzymic, and immunological studies of chemically modified derivatives
1970 StandoutNobel
Antibody-Mediated Destruction of Virus-Infected Cells
1980
Inhibition of Complement by Culture Supernatants of Aspergillus fumigatus
1986
Modification of the Single Tryptophan Residue of Staphylococcal Nuclease by a New Mild Oxidizing Agent
1970 StandoutNobel
Microbial surfaces in relation to pathogenicity
1977
Is Cytosolic Ionized Calcium Regulating Neutrophil Activation?
1983 StandoutScienceNobel
Inactivation of C5a Anaphylatoxin by a Peptide That Is Complementary to a Region of C5a
2004 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets.
1987 StandoutNobel
Immune reactants in cryoproteins. Relationship to complement activation.
1977
Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody
1978
In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions
1977
The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells
1993
Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses
1991
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
1986 Standout
Selective deficiency of the second component of complement in a patient with anaphylactoid purpura
1975
Central nervous system disease in systemic lupus erythematosus
1975 Standout
The human complement system
1975
Breakdown of the blood-cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus
1981 StandoutNobel
Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III
2000 StandoutNobel
Antibody immunity and invasive fungal infections
1995
Direct measurement of the increase in intracellular free calcium ion concentration in response to the action of complement
1981
Biology of Endotoxin
1976
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Evolution at Two Levels in Humans and Chimpanzees
1975 StandoutScience
A new complement function: solubilization of antigen-antibody aggregates.
1975
The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli
1985 Standout
Innate Immune Responses to Microbial Poisons: Discovery and Function of the Toll-Like Receptors
2003 StandoutNobel
Biosynthesis of Complement
1976
The effects of bacterial endotoxins on host mediation systems. A review.
1978
Semisynthetic Analogues of an Enzymically Active Complex Formed between Two Overlapping Fragments of Staphylococcal Nuclease
1971 StandoutNobel
Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients
1980 Standout
The Pathogenesis of Dermatitis Herpetiformis
1978
Hemolytic-Uremic Syndrome: Current Concepts and Management
1982
Works of Joseph E. May being referenced
Activation of the Alternate Complement Pathway by Human Immunoglobulins
1976
The Role of Late Complement Components and the Alternate Complement Pathway in Experimental Cryptococcosis
1973
Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
1973
IN VITRO STUDIES OF COMPLEMENT FUNCTION IN SERA OF C4-DEFICIENT GUINEA PIGS
1971
Host Defense Against Bacterial Endotoxemia-Contribution of The Early and Late Components of Complement to Detoxification
1972
Hemolysis of Sheep Erythrocytes in Guinea Pig Serum Deficient in the Fourth Component of Complement
1973
Contributions of the Classical and Alternate Complement Pathways to the Biological Effects of Endotoxin
1973
Paroxysmal Nocturnal Hemoglobinuria
1973
The immunologic role of methionine and cysteine residues in ribonuclease
1968
The Role of the Classical and Alternate Complement Pathways in Host Defenses Against Cryptococcus Neoformans Infection
1974
A New Complement-Mediated Cytolytic Mechanism—the C1-Bypass Activation Pathway
1973
Interactions of the Classical and Alternate Complement Pathway with Endotoxin Lipopolysaccharide EFFECT ON PLATELETS AND BLOOD COAGULATION
1973
Complement-Mediated Tissue Damage: Contribution of the Classical and Alternate Complement Pathways in the Forssman Reaction
1972